Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Calliditas Therapeutics (DE:LC8A)
FRANKFURT:LC8A
Holding DE:LC8A?
Track your performance easily
See the Price Targets and Ratings of:
LC8A Analyst Ratings
Currently, no data available
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
LC8A Stock 12 Month Forecast
There Are No Analyst Ratings for DE:LC8A In The Last 3 Months.
| Highest Price Target― | Average Price Target― | Lowest Price Target― |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
LC8A Financial Forecast
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Citi
€35.01
Hold
-0.54%
Downside
Downgraded
05/30/24
Calliditas Therapeutics downgraded to Neutral from Buy at CitiCalliditas Therapeutics downgraded to Neutral from Buy at Citi
LifeSci Capital
€39.5→€35.01
Hold
-0.54%
Downside
Downgraded
05/28/24
Maintaining Hold Rating Amidst Calliditas Acquisition by Asahi Kasei: Assessing the Premium Offer and Strategic Fit
Stifel Nicolaus
€49.37→€35.91
Hold
2.01%
Upside
Downgraded
05/28/24
Analysts Offer Insights on Healthcare Companies: Allakos (NASDAQ: ALLK), Calliditas Therapeutics (NASDAQ: CALT) and Clene (NASDAQ: CLNN)
Jefferies
€52.07→€35.01
Hold
-0.54%
Downside
Downgraded
05/28/24
Maintaining Hold on Calliditas: Assessing Acquisition Fairness Amid Evolving IgAN Market Dynamics
H.C. Wainwright
€40.4→€35.01
Hold
-0.54%
Downside
Downgraded
05/28/24
Asahi Kasei's Acquisition of Calliditas Therapeutics: A Hold Rating with Revised Price Target
LC8A Analyst Recommendation Trends
Rating
Dec 23
Feb 24
Mar 24
Apr 24
May 24
Strong Buy
9
12
9
7
7
Buy
0
0
0
0
0
Hold
0
0
0
0
6
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
9
12
9
7
13
Each month's total comprises the sum of three months' worth of ratings.
LC8A Stock Forecast FAQ
What is DE:LC8A’s average 12-month price target, according to analysts?
Currently, no data Available
What is DE:LC8A’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:LC8A, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Calliditas Therapeutics a Buy, Sell or Hold?
Currently, no data Available
What is Calliditas Therapeutics’s share price target?
Currently, no data Available
What do analysts say about Calliditas Therapeutics?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Calliditas Therapeutics?
To buy shares of DE:LC8A, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.